Replies to post #100027 on Ayala Pharmaceuticals Inc (ADXS)

[$5.95akadawson-m]

This is what occurred today at 10 COMBINATIONS 360

Advaxis


Joel R Hecht, MD
Professor of Clinical Medicine, David Geffen School of Medicine / Director, Gastrointestinal Oncology Program, University of California Los Angeles (UCLA)(on behalf of Advaxis)

[ubmmg]

I bet they haven’t had anything new to present. When was the last update? Less than a month ago? Does someone believe the company would come up with new data every month?
I expected them to start issuing fluff PRs around this time to attempt a secondary once the share price moves north. It hasn’t happened yet. I’m curious why they don’t follow their footsteps. Maybe, they have something else brewing? I hope so but history taught me a different lesson.

[mypekeispooped]

I don't think they would present bad data at an event but I HOPE they would PR good data.